AIM1 hypermethylation is associated with bladder cancer, nasopharyngeal carcinoma, and melanoma.[25,26] However, AIM1 is highly overexpressed in prostate cancer tissue.[27] Another study on AIM1 and prostate cancer showed that advanced prostate cancer is usually accompanied by AIM1 deletion and decreased expression. Here, CRYBG1 is linked to urinary bladder carcinoma.